Related Experiment Video
Updated: Jun 8, 2026
07:15
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science
1Department of Medicine, GIDRU and Division of Infectious Diseases, Queen's University, Kingston, ON Canada.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|October 5, 2010
Summary
Probiotics, derived from gut bacteria, offer clinical benefits for gastrointestinal issues. While strain-specific, they share anti-inflammatory and host-protective effects, with safety also considered.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Intestinal microbiota are crucial for gastrointestinal health.
- Probiotics, derived from gut bacteria, offer clinical benefits.
- Probiotic efficacy is strain-specific and mechanism-dependent.
Purpose of the Study:
- To review selected probiotics with available clinical and mechanistic data.
- To discuss common features and strain-specific effects of probiotics.
- To address the safety of probiotic formulations.
Main Methods:
- Review of existing clinical and mechanistic data for selected probiotics.
- Focus on specific examples: VSL#3, E. coli Nissle 1917, LGG, L. reuteri, and S. boulardii.
- Analysis of shared probiotic mechanisms and strain-specific actions.
Main Results:
- Probiotics exert anti-inflammatory effects.
- They antagonize competing microorganisms through various strategies.
- Probiotics enhance host barrier function and upregulate cytoprotective proteins.
Conclusions:
- Probiotic benefits are strain-specific, with diverse mechanisms of action.
- Common features include anti-inflammatory and cytoprotective effects.
- Safety is a critical consideration for probiotic use.
Related Concept Videos
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:18Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...